PT  - JOURNAL ARTICLE
AU  - Alexa B Adams
AU  - Michael Kazim
AU  - Thomas J A Lehman
TI  - Treatment of orbital myositis with adalimumab (Humira).
DP  - 2005 Jul 01
TA  - The Journal of Rheumatology
PG  - 1374--1375
VI  - 32
IP  - 7
4099  - http://www.jrheum.org/content/32/7/1374.short
4100  - http://www.jrheum.org/content/32/7/1374.full
SO  - J Rheumatol2005 Jul 01; 32
AB  - Adalimumab is a fully humanized IgG1 monoclonal antibody to tumor necrosis factor-a. We describe 2 patients (17 and 13 years of age) with refractory, steroid-dependent, recurrent nonspecific orbital myositis not controlled with standard immunosuppressive medications. Both improved with adalimumab treatment, allowing reduction in corticosteroid dosage without disease flare.